Stock Taper
EXCHANGE TRADED FUND

XBI

State Street SPDR S&P Biotech ETF
$162.38 ▼ 3.48%
−$5.85 TODAY

FUND FACTS

Manager SPDR
Assets $12B
Expense ratio 0.35%
Inception Jan 31, 2006
Asset class Equity
Holdings 146
Volume 9.79M
Avg volume 8.75M

ABOUT THIS FUND

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

PRICE

$162.38 ▼ DOWN 3.48% (−$5.85)
$162$164$165$1679:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM162.38

HOLDINGS

TOP 20 OF 146 · 27.90% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 MRNA Moderna, Inc. 2.76% 2.3M $333.22M
02 TWST Twist Bioscience Corporation 2.01% 1.56M $242.48M
03 APGE Apogee Therapeutics, Inc. 1.45% 1.28M $175.13M
04 NTRA Natera, Inc. 1.39% 489.67K $167.94M
05 KYMR Kymera Therapeutics, Inc. 1.37% 1.36M $164.97M
06 RVMD Revolution Medicines, Inc. 1.36% 735.13K $164.62M
09 ORKA Oruka Therapeutics, Inc. 1.34% 1.66M $161.83M
10 DNTH Dianthus Therapeutics, Inc. 1.30% 1.39M $156.69M
11 ERAS Erasca, Inc. 1.30% 7.93M $156.48M
12 TVTX Travere Therapeutics, Inc. 1.28% 2.27M $155.07M
13 CGON CG Oncology Inc. 1.28% 1.93M $154.43M
15 PCVX Vaxcyte, Inc. 1.20% 2.33M $144.54M
17 REGN Regeneron Pharmaceuticals, Inc. 1.19% 176.16K $144.08M
18 ROIV Roivant Sciences Ltd. 1.18% 3.73M $142M
20 INSM Insmed Incorporated 1.17% 1.15M $141.81M

SECTOR HOLDINGS

TECHNOLOGY IS 99.60% OF THE FUND
Healthcare 99.60%
Financial Services 0.40%

BY REGION

UNITED STATES IS 95.47% OF THE FUND
United States 95.47%
United Kingdom 1.18%
Ireland 1.11%
Switzerland 1.07%
Netherlands 1.06%
Other 0.12%